Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)

GHAPPcast

Health EN ↓ 170 episodes

This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).   Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

Be sure to visit the podcast's website and support the creator: ghappcast.captivate.fm

Author

Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)

Category

Health

Podcast website

ghappcast.captivate.fm

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Medication Review: Are There Any Head to Head Studies with Guselkumab? 17.11.2026

Thank you to Johnson & Johnson. for the support of this medication review. Explore guselkumab (Tremfya) versus ustekinumab (Stelara) for moderately to severely active Crohn’s disease in this GHAPP medication review with Kimberly Orleck, PA-C. This educational video examines head-to-head evidence from the phase 3 GALAXI 2 and GALAXI 3 clinical trials and the relevance of their week 48 results t...

FAQ: HCV: Is It Still an Issue? 12.11.2026

Despite advances in hepatitis C treatment, why does hepatitis C virus (HCV) remain a significant public health concern, and what can healthcare providers do to improve diagnosis and access to care? In this educational video, Scott Springer, PA-C, a healthcare professional specializing in hepatology and addiction medicine in Buffalo, New York, discusses the ongoing challenges of hepatitis C screeni...

Podcast: Keep Calm and Liver On 10.11.2026

What are the most common complications after liver transplantation, and how can healthcare providers recognize and manage them to improve patient outcomes? In this educational session from the 9th Annual GHAPP National Conference, Edith Johannes explores the clinical and emotional challenges patients face before and after liver transplant surgery. This discussion highlights the psychological impac...

Podcast: Behind the Scenes of GHAPP National Planning 05.11.2026

What does it take to bring one of the leading gastroenterology and hepatology conferences for advanced practice providers (APPs) to life? In this behind-the-scenes podcast, GHAPP board members Christina Hanson, FNP-C, Amy Ladewski, PA-C, and Patrick Horne, NP, share an inside look at the planning, collaboration, and dedication behind the GHAPP National Conference. From developing a comprehensive e...

Podcast: AI in GI: Hype, Help, or the Future 03.11.2026

How is artificial intelligence transforming gastroenterology, and is it truly improving patient care or simply generating hype? In this video, Sarah Enslin, PA-C, of the University of Rochester Medical Center, explores the evolving role of AI in gastroenterology and its potential to enhance clinical efficiency, diagnostic accuracy, and patient outcomes. From AI-assisted colonoscopy and computer-ai...

Podcast: What is the GHAPP Peer Network? 29.10.2026

Discover the GHAPP Peer Network, a collaborative community designed to connect gastroenterology (GI), hepatology, and other advanced practice providers (APPs) nationwide. In this video, nurse practitioners HoChong Gilles, Oyin Penny, and Suzanne Robertazzi introduce the GHAPP Peer Network and explore how this innovative platform supports peer-to-peer learning, clinical collaboration, mentorship, a...

Linerixibat Medication Review 22.09.2026

Christina Hanson, FNP, and Dr. Marcelo Kugelmas of South Denver Gastroenterology review linerixibat, an ileal bile acid transporter (IBAT) inhibitor, and its role in managing cholestatic pruritus in primary biliary cholangitis (PBC). This medication review podcast explores how blocking bile acid reabsorption in the ileum targets a pathway involved in persistent itching. The discussion covers the p...

Podcast: Managing Fatigue and Pruritus in Your Patients With PBC 15.09.2026

How can clinicians better recognize and manage itching and fatigue in primary biliary cholangitis (PBC)? In this podcast, hepatology clinicians from RUSH University Medical Center discuss the impact of PBC-related pruritus and fatigue on sleep, daily activities, and quality of life. The conversation explores proactive symptom screening, assessing itch severity, and individualizing treatment with o...

Podcast: How to Screen and Diagnose Cholestatic Liver Diseases 25.08.2026

In this episode, HoChong Gilles of the Richmond VA Medical Center, and Alison Moe of Atlanta Gastroenterology discuss a practical, step-by-step approach to screening for and diagnosing cholestatic liver disease. The conversation reviews how to recognize a cholestatic liver test pattern, evaluate symptoms such as pruritus and jaundice, and confirm that an elevated alkaline phosphatase is hepatic in...

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy 18.08.2026

Thank you to Salix for their support on this podcast episode. In this GHAPP podcast, host Christina Hanson, FNP, welcomes Janet Gripshover, DNP, FNP-BC, MBA, for a practical discussion on recognizing and managing overt hepatic encephalopathy (OHE) in patients with chronic liver disease and cirrhosis. The episode reviews how liver disease may progress from fibrosis to compensated and decompensated...

FAQ: Counseling Patients on Overt Hepatic Encephalopathy 11.08.2026

Thank you to Salix for their support on this FAQ video module. In this FAQ video module, Natalie Oliver, PA-C, discusses how healthcare professionals can counsel patients and caregivers about overt hepatic encephalopathy (OHE). This educational overview explains how cirrhosis and portal hypertension can reduce the liver’s ability to clear toxins from the blood, potentially leading to changes in th...

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy 04.08.2026

Thank you to Salix for their support on this FAQ video module. In this FAQ video module, Samantha Ramirez, NP-C, discusses how healthcare professionals can identify and diagnose overt hepatic encephalopathy (OHE) in patients with severe liver disease or cirrhosis. This educational overview highlights early signs that may be subtle or vary between patients, including changes in sleep patterns, slow...

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD 23.07.2026

Thank you to Johnson & Johnson for their support on this podcast episode. In this GHAPP podcast, Amy Stewart, NP, of Capital Digestive Care, introduces a practical inflammatory bowel disease discussion with Amanda Wilhite, PA-C, of Houston Methodist Gastroenterology Associates. The episode explores how healthcare professionals may approach the two FDA-approved subcutaneous guselkumab maintenan...

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC 30.06.2026

Thank you to AbbVie for their support of this Medication Review Video Module. In this medication review, Melissa Ferrari, PA, and Jennifer Hamilton, MSPAS, PA-C, provide a comprehensive overview of the INSPIRE and COMMAND clinical trials evaluating risankizumab for the treatment of moderately to severely active ulcerative colitis. The discussion reviews the trial design, patient populations, induc...

Med Review: SEQUENCE Trial: Risankizumab vs Ustekinumab in Anti-TNF-Refractory Crohn’s Disease 09.06.2026

Thank you to AbbVie for their support on this Medication Review Video Module. In this medication review, Sharon Dudley-Brown, CRNP, PhD from Johns Hopkins University and Angelina Collins, MSN, ANP-BC, from the University of California San Diego, provide a comprehensive overview of the SEQUENCE trial, a landmark head-to-head study comparing risankizumab and ustekinumab in patients with moderate to...

FAQ: QUASAR Long Term Extension Interim Analysis 02.06.2026

Thank you to Johnson & Johnson for their support on this FAQ Video Module. In this educational video, Jamie Brogan, APRN, from Northwestern Medicine, reviews the latest QUASAR long-term extension data evaluating the efficacy and safety of guselkumab in adults with moderate to severe ulcerative colitis. This discussion highlights approximately two years of follow-up data, offering healthcare pr...

Medication Review: Guselkumab IV vs SC Formulation 28.05.2026

Thank you to Johnson & Johnson for their support on this Medication Review Video Module. In this quick educational video, Angelina Collins, NP, from the University of California San Diego Inflammatory Bowel Disease Center, discusses an important question in Crohn’s disease treatment. This overview breaks down the key findings from the GALAXI and GRAVITI clinical trials in a clear, practical wa...

FAQ: Recognizing OHE Risk in Patients with Chronic Liver Disease 26.05.2026

Thank you to Salix for the support on this FAQ Video Module. This educational FAQ module, featuring Mikhail Alper, PA-C focuses on recognizing risk factors and early clinical indicators of Overt Hepatic Encephalopathy (OHE) in patients with chronic liver disease and cirrhosis. A central focus is placed on subtle and often underrecognized manifestations of OHE risk, including disrupted sleep, wake...

FAQ: Phase 3 GALAXI 2 & 3: Extraintestinal Manifestations In Moderate to Severe Crohn’s Disease 19.05.2026

Thank you to Johnson & Johnson for the support on this FAQ Video Module. This FAQ video features Janette Villalon, PA, who reviews the role of guselkumab in treating extraintestinal manifestations in patients with moderately to severely active Crohn’s disease. In this expert-led discussion, she summarizes findings from the GALAXI 2 and GALAXI 3 clinical trials presented at a 2026 medical congr...

Medication Review: Monotherapy vs. Combination Therapy: Relevance in IBD Treatment Strategy 14.05.2026

Thank you to Celltrion for the support on this Medication Review Video Module. This medication review explores the evolving role of monotherapy versus combination therapy in the treatment of inflammatory bowel disease (IBD), with a focus on biologic optimization and patient-centered treatment strategies. In this expert-led discussion, Brooke Hodnick, PA, from Texas Digestive Disease Consultants, r...

Medication Review: Stable PK Supporting Continuous Inflammatory Control 07.05.2026

Thank you to Celltrion for the support on this Medication Review Video Module. This medication review explores the role of stable pharmacokinetics (PK) in achieving continuous inflammatory control in inflammatory bowel disease (IBD), with a focus on subcutaneous infliximab therapy for Crohn’s disease and ulcerative colitis. Kim Orleck, PA-C, from Atlanta Gastroenterology Associates and United Dige...

Journal Club: ASTRO Phase 3 Study: Efficacy and Safety of SC Guselkumab 28.04.2026

Thank you to Johnson & Johnson for the support on this Journal Club Review Module. In this journal club video, Sharon Dudley Brown, CRNP, PhD, from the IBD Center at Johns Hopkins University, reviews the ASTRO trial published in The Lancet, which evaluated subcutaneous guselkumab for the treatment of moderate to severe ulcerative colitis. The discussion highlights how this IL-23 inhibitor was...

Journal Club: Benefit–Risk Profile of Upadacitinib in Patient’s With Moderate to Severe UC and CD 21.04.2026

Thank you to AbbVie for the support on this Journal Club Review Module. This journal club review episode explores the benefit–risk profile of Upadacitinib for patients with moderately to severely active Ulcerative Colitis and Crohn’s Disease, based on a post hoc analysis of phase 2b/3 clinical trials. Featuring expert insights from Sally Bowa, APNP, FNP-C and Jennifer Labas, MSN, in both community...

Podcast: How Do You Best Support Patients Getting Started on New MASH Treatments? 14.04.2026

Learn how to effectively support patients starting treatment for MASH with this practical, clinician-focused discussion featuring expert advanced practice providers. In this episode, hepatology specialists Robin Soto and Alison Moe break down how to set realistic expectations, define meaningful treatment goals beyond the scale, and guide patients through long-term lifestyle and pharmacologic manag...

Podcast: Best Practices For Patient Identification 07.04.2026

Stay up to date on MASH and MASLD with expert insights from nurse practitioners Sarah Dawkins of Duke University Medical Center and Edith Johannes of UCLA Health. This episode focuses on best practices for identifying at-risk patients, including those with steatosis on imaging, cardiometabolic risk factors, and elevated BMI—highlighting why early screening is critical to preventing progression to...

Listen to the GHAPPcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.